Factory Kupereka mwachindunji 4-Dibuthylamino-2-Hydroxybenzophenone-2-Carboxylic Acid (BBA) CAS 54574-82-2

Nthawi zambiri timaganiza ndikuchita mogwirizana ndi kusintha kwa zochitika zanu, ndikukula.Tikufuna kukwaniritsa malingaliro ndi thupi lolemera komanso kukhala ndi moyo ku Factory Kupereka mwachindunji 4-Dibuthylamino-2-Hydroxybenzophenone-2-Carboxylic Acid (BBA) CAS 54574-82-2, Cholinga chathu chikhala kuthandiza makasitomala kudziwa zolinga zawo. .Takhala tikupanga zoyesayesa zabwino kuti tikwaniritse zovuta izi ndikukulandirani ndi mtima wonse kuti mulembetse kwa ife.
Nthawi zambiri timaganiza ndikuchita mogwirizana ndi kusintha kwa zochitika zanu, ndikukula.Timayesetsa kukwaniritsa malingaliro ndi thupi lolemera komanso kukhala ndi moyoChina 4-Dibuthylamino-2-Hydroxybenzophenone and Bba, Kupezeka kwathu kosalekeza kwa zinthu zamagiredi apamwamba ndi mayankho ophatikizana ndi ntchito yathu yabwino kwambiri yogulitsa zisanadze ndi kugulitsa pambuyo pake kumatsimikizira kupikisana kwakukulu pamsika womwe ukuchulukirachulukira padziko lonse lapansi.landirani makasitomala atsopano ndi akale ochokera m'mitundu yonse kuti mutilumikizane ndi mabizinesi am'tsogolo komanso kuchita bwino!

2'-Methoxy-3'-nitro-biphenyl-3-carboxylic acid amagwiritsidwa ntchito ngati wapakatikati wa Eltrombopag.
Eltrombopag, yopangidwa ndi GlaxoSmithKline (GSK) ku UK ndipo pambuyo pake idapangidwa limodzi ndi Novartis ku Switzerland, ndiye woyamba komanso wovomerezeka wa agonist ang'onoang'ono omwe si peptide TPO receptor agonist padziko lapansi.Eltrombopag idavomerezedwa ndi US FDA mu 2008 pochiza idiopathic thrombocytopenic purpura (ITP), komanso mu 2014 pochiza aplastic anemia (AA).Ndiwonso mankhwala oyamba ovomerezedwa ndi US FDA pochiza AA m'zaka 30 zaposachedwa.
Mu december2012, US FDA inavomereza Eltrombopag zochizira thrombocytopenia odwala matenda a chiwindi C (CHC), kuti odwala matenda a chiwindi C ndi osauka matenda chifukwa otsika kupatsidwa zinthu za m`mwazi kuwerenga akhoza kuyamba ndi kusunga interferon zochokera muyezo mankhwala kwa matenda a chiwindi.Pa february3, 2014, GlaxoSmithKline adalengeza kuti FDA idapereka chithandizo chamankhwala chopambana cha Eltrombopag pochiza hemopenia kwa odwala omwe ali ndi chemicalbook aplastic anemia (SAA) omwe sanayankhe mokwanira ku immunotherapy.Pa Ogasiti 24, 2015, US FDA idavomereza Eltrombopag kuti azichiza thrombocytopenia mwa akulu ndi ana azaka za 1 ndi kupitilira omwe ali ndi matenda osachiritsika a immune thrombocytopenia (ITP) omwe alibe yankho lokwanira ku corticosteroids, immunoglobulins kapena splenectomy.Pa january4, 2018, Eltrombopag idavomerezedwa kuti ilembedwe ku China kuti ichiritse primary immune thrombocytopenia (ITP).

Nthawi zambiri timaganiza ndikuchita mogwirizana ndi kusintha kwa zochitika zanu, ndikukula.Tikufuna kukwaniritsa malingaliro ndi thupi lolemera komanso kukhala ndi moyo ku Factory Kupereka mwachindunji 4-Dibuthylamino-2-Hydroxybenzophenone-2-Carboxylic Acid (BBA) CAS 54574-82-2, Cholinga chathu chikhala kuthandiza makasitomala kudziwa zolinga zawo. .Takhala tikupanga zoyesayesa zabwino kuti tikwaniritse zovuta izi ndikukulandirani ndi mtima wonse kuti mulembetse kwa ife.
Factory mwachindunji kuperekaChina 4-Dibuthylamino-2-Hydroxybenzophenone and Bba, Kupezeka kwathu kosalekeza kwa zinthu zamagiredi apamwamba ndi mayankho ophatikizana ndi ntchito yathu yabwino kwambiri yogulitsa zisanadze ndi kugulitsa pambuyo pake kumatsimikizira kupikisana kwakukulu pamsika womwe ukuchulukirachulukira padziko lonse lapansi.landirani makasitomala atsopano ndi akale ochokera m'mitundu yonse kuti mutilumikizane ndi mabizinesi am'tsogolo komanso kuchita bwino!